CyclopharmASX:CYC -4.08%46 Days Inventory is 319.90 as of Dec. 2025, which is 4% below its 10-year median of 334.19. GuruFocus rates ASX:CYC with a GF Score™ of 46/100 and a GF Value™ of A$0.84 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 115 Medical Distribution companies, Cyclopharm ranks worse than 98.26% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Cyclopharm's Average Total Inventories for the
six
months ended in Dec. 2025 was A$12.81 Mil. Cyclopharm's Cost of Goods Sold for the
six
months ended in Dec. 2025 was A$7.31 Mil.
Hence, Cyclopharm's Days Inventory for the
six
months ended in Dec. 2025 was 319.90.
The historical rank and industry rank for Cyclopharm's Days Inventory or its related term are showing as below:
ASX:CYC'
s Days Inventory Range Over the Past 10 Years
Min: 251.04 Med: 334.19 Max: 442.43
Current: 326.71
During the past 13 years, Cyclopharm's highest Days Inventory was 442.43. The lowest was 251.04. And the median was 334.19.
ASX:CYC's Days Inventory is ranked worse than 98.26% of 115
companies
in the Medical Distribution industry
Industry Median: 57.73
vs ASX:CYC: 326.71
Cyclopharm's Days Inventory
declined
from Dec. 2024 (505.66) to Dec. 2025 (319.90).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cyclopharm's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.57.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cyclopharm's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 74.03.
Cyclopharm (ASX:CYC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cyclopharm's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cyclopharm's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cyclopharm Days Inventory Related Terms
Cyclopharm Days Inventory Historical Data
* Premium members only.
The historical data trend for Cyclopharm's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:CYC vs MCK, CAH, COR: Days Inventory Comparison
For the Medical Distribution subindustry, Cyclopharm's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cyclopharm Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cyclopharm's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cyclopharm's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cyclopharm (ASX:CYC) has a Days Inventory of 319.90 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cyclopharm and its competitors. This is near median its historical median of 334.19. Over the past decade, Cyclopharm's Days Inventory has ranged from 251.04 to 442.43. According to the industry distribution chart, Cyclopharm ranks #113 out of 115 companies in the Medical Distribution industry, placing it in the top 98.3%.
Is Cyclopharm's Days Inventory too high?
Cyclopharm's current Days Inventory of 319.90 is near median its 10-year median of 334.19. Over the past 10 years, this metric has ranged from a low of 251.04 to a high of 442.43. The Medical Distribution industry median Days Inventory is 57.73. Cyclopharm's value of 319.90 is 454.1% above this industry median. Based on the distribution chart, Cyclopharm ranks #113 out of 115 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Cyclopharm has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cyclopharm's Days Inventory compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Cyclopharm ranks #113 out of 115 companies for Days Inventory. This places Cyclopharm in the lower half of its industry. The industry median Days Inventory is 57.73. Cyclopharm's value of 319.90 is 454.1% above this benchmark. Historically, Cyclopharm's own Days Inventory has ranged from 251.04 to 442.43 over the past decade. While the company's 10-year median is 334.19 vs. the industry median of 57.73, Cyclopharm has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 57.73, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cyclopharm's current Days Inventory of 319.90 is 454.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cyclopharm and its competitors. For the Medical Distribution industry, the median Days Inventory is 57.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cyclopharm's current Days Inventory is 319.90, which is near median its own 10-year median of 334.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclopharm stock overvalued right now?
Based on GuruFocus' analysis, Cyclopharm (ASX:CYC) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.84, compared to a current price of A$0.47 — trading 44% below its estimated fair value. The current Days Inventory is 319.90, which is near median its 10-year median of 334.19 and 454.1% above the Medical Distribution industry median of 57.73. Cyclopharm's overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cyclopharm (ASX:CYC), the current Days Inventory is 319.90 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cyclopharm (ASX:CYC) Overvalued in 2026?
Based on GuruFocus' analysis, Cyclopharm stock appears to be undervalued.
The current stock price of A$0.47 is trading 44% below its estimated GF Value™ of A$0.84.
GuruFocus considers Cyclopharm to be Possible Value Trap.
Key valuation signals for ASX:CYC:
Days Inventory: 319.90 (near median its 10-year median of 334.19)
GF Value™: A$0.84 vs. price of A$0.47 (44% below fair value)
Industry Position: 454.1% above the Medical Distribution median (#113 of 115)
No single metric tells the full story. See the ASX:CYC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cyclopharm Ltd is a health technology company offering solutions related to functional lung ventilation imaging. Its proprietary product Technegas is a broad-spectrum diagnostic lung imaging technology product for the visualisation of pulmonary ventilation and lung function. The company sells its products to healthcare institutions and medical professionals. Maximum revenue is generated from its Technegas products and services, which include the sale of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. Geographically, the company generates maximum revenue from its business in Europe, and the rest from Asia Pacific, Canada, the USA, and other regions.
46GF Score
Get the complete analysis for ASX:CYC
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CYC has been successfully added to your 
